# Shuichi Ito

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shuichi-ito/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,209 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 56 |
| i10-index | 258 |
| Last Known Institution | Yokohama City University |
| OpenAlex ID | https://openalex.org/A5072056487 |
| ORCID iD | 0000-0002-5242-8987 |
| Works | 614 |

## Researcher papers

- [Effects of resin hydrophilicity on water sorption and changes in modulus of elasticity](https://scholariq.org/papers/effects-of-resin-hydrophilicity-on-water-sorption-and-changes-in-modulus-of/)
- [Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)](https://scholariq.org/papers/revision-of-diagnostic-guidelines-for-kawasaki-disease-6th-revised-edition/)
- [Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/rituximab-for-childhood-onset-complicated-frequently-relapsing-nephrotic/)
- [Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease](https://scholariq.org/papers/creatinine-based-equation-to-estimate-the-glomerular-filtration-rate-in-japanese/)
- [Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury](https://scholariq.org/papers/chloroquine-and-inhibition-of-toll-like-receptor-9-protect-from-sepsis-induced/)
- [Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children](https://scholariq.org/papers/single-dose-of-rituximab-for-refractory-steroid-dependent-nephrotic-syndrome-in/)
- [Conversion of one-step to two-step self-etch adhesives for improved efficacy and extended application.](https://scholariq.org/papers/conversion-of-one-step-to-two-step-self-etch-adhesives-for-improved-efficacy-and/)
- [Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus‐prone NZB × NZW mice](https://scholariq.org/papers/suppressive-oligodeoxynucleotides-delay-the-onset-of-glomerulonephritis-and/)
- [A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment](https://scholariq.org/papers/a-multicenter-randomized-trial-indicates-initial-prednisolone-treatment-for/)
- [Effects of surface pre-reacted glass-ionomer fillers on mineral induction by phosphoprotein](https://scholariq.org/papers/effects-of-surface-pre-reacted-glass-ionomer-fillers-on-mineral-induction-by/)
- [Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan](https://scholariq.org/papers/real-world-safety-profile-of-eculizumab-in-patients-with-paroxysmal-nocturnal/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Gestational Diabetes Research and Management](https://scholariq.org/topics/gestational-diabetes-research-and-management/)
- [Dental materials and restorations](https://scholariq.org/topics/dental-materials-and-restorations/)
- [Birth, Development, and Health](https://scholariq.org/topics/birth-development-and-health/)

## Researcher university

- [Yokohama City University](https://scholariq.org/institutions/yokohama-city-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.